D. It reduces potassium competition at the Na+/K+-ATPase binding site, enhancing digoxin effect
Why this is correct
Digoxin inhibits myocardial Na+/K+-ATPase, increasing intracellular sodium, reducing sodium-calcium exchanger activity, and thereby increasing intracellular calcium and contractility. Extracellular potassium competes with digoxin for binding to the pump; hypokalemia increases pump inhibition and arrhythmia risk. Renal dysfunction can independently increase digoxin exposure. Hypomagnesemia is another important risk factor.
Why each option is correct or incorrect
Digoxin toxicity is not primarily explained by increased hepatic generation of a toxic metabolite.
Protein binding is not the key reason low potassium heightens toxicity.
Worsened renal function can decrease, not increase, digoxin clearance.
Correct: less extracellular potassium permits greater digoxin interaction with Na+/K+-ATPase.
High-yield notes
- Digoxin inhibits Na+/K+-ATPase.
- Hypokalemia and hypomagnesemia predispose to digoxin toxicity.
- Life-threatening poisoning may require digoxin-specific antibody fragments.
Loop diuretic + hypokalemia + digoxin = classic proarrhythmic interaction.
Acute massive digoxin poisoning may cause hyperkalemia, unlike chronic toxicity potentiated by hypokalemia.